As the treated skin begins to shed, new cells replace the old layer, resulting in improved clarity, smoother texture, and a revived glow
FDAs 2025 Increase in Warning Letters on Compounded Drug Advertising In recent remarks at the Food and Drug Law Institutes Enforcement, Litigation, and Compliance Conference, the director of the Office of Compliance within FDAs Center for Drug Evaluation and Research's (CDER) noted that 22% of warning letters that CDER issued in fiscal year (FY) 2025 were sent to telehealth platforms and other entities related to claims made regarding compounded drug products, including compounded GLP-1s
This clean, targeted action is why its so highly regarded in the research community
Patients with a history of pancreatitis, thyroid cancer, or severe kidney disease require careful provider evaluation before starting any GLP-1
Genetic therapy approaches for ornithine transcarbamylase deficiency
She took the time to thoroughly explain the process, what to expect, and answered all of my questions." Google Review Wichita, KS "Paige is the SWEETEST